HomeCompareLBRG vs MRK

LBRG vs MRK: Dividend Comparison 2026

LBRG yields 14388.49% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBRG wins by $2005708871003771392.00M in total portfolio value
10 years
LBRG
LBRG
● Live price
14388.49%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2005708871003771392.00M
Annual income
$1,978,657,258,734,465,300,000,000.00
Full LBRG calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LBRG vs MRK

📍 LBRG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBRGMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBRG + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBRG pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBRG
Annual income on $10K today (after 15% tax)
$1,223,021.58/yr
After 10yr DRIP, annual income (after tax)
$1,681,858,669,924,295,300,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LBRG beats the other by $1,681,858,669,924,295,300,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBRG + MRK for your $10,000?

LBRG: 50%MRK: 50%
100% MRK50/50100% LBRG
Portfolio after 10yr
$1002854435501885696.00M
Annual income
$989,328,629,367,232,700,000,000.00/yr
Blended yield
98.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LBRG
No analyst data
Altman Z
4.6
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBRG buys
0
MRK buys
0
No recent congressional trades found for LBRG or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBRGMRK
Forward yield14388.49%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2005708871003771392.00M$56.8K
Annual income after 10y$1,978,657,258,734,465,300,000,000.00$9,798.13
Total dividends collected$2003918040391760896.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LBRG vs MRK ($10,000, DRIP)

YearLBRG PortfolioLBRG Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,449,549$1,438,848.92$11,206$366.19+$1.44MLBRG
2$196,474,559$194,923,542.10$12,650$502.35+$196.46MLBRG
3$24,902,096,749$24,691,868,970.40$14,407$694.19+$24902.08MLBRG
4$2,951,469,517,816$2,924,824,274,294.62$16,585$967.82+$2951469.50MLBRG
5$327,138,211,038,176$323,980,138,654,113.20$19,342$1,363.89+$327138211.02MLBRG
6$33,910,472,885,988,016$33,560,435,000,177,170.00$22,913$1,947.19+$33910472885.97MLBRG
7$3,287,504,337,429,561,000$3,251,220,131,441,553,400.00$27,662$2,823.89+$3287504337429.53MLBRG
8$298,092,086,846,622,500,000$294,574,457,205,572,900,000.00$34,159$4,173.35+$298092086846622.44MLBRG
9$25,281,880,625,519,608,000,000$24,962,922,092,593,716,000,000.00$43,337$6,308.80+$25281880625519608.00MLBRG
10$2,005,708,871,003,771,300,000,000$1,978,657,258,734,465,300,000,000.00$56,776$9,798.13+$2005708871003771392.00MLBRG

LBRG vs MRK: Complete Analysis 2026

LBRGStock

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area. The company is also developing Solar Tracer, a solar collector that would use concentrating solar power technology to capture energy from the sun and transfer it in the form of heat to run steam turbine generators. In addition, it offers health supplements for men and women that help with issues, such as sleeplessness, headaches, aches and pains, mood improvement, energy, calm support, and appetite control; athletic supplements to enhance and sustain athletic performance; and nutritional supplement products. The company intends to sell its health products and formulas through wholesale channels; or license products to other manufacturers or multi-level marketing organizations. Ladybug Resource Group was founded in 2007 and is based in Kirkland, Washington.

Full LBRG Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LBRG vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBRG vs SCHDLBRG vs JEPILBRG vs OLBRG vs KOLBRG vs MAINLBRG vs JNJLBRG vs ABBVLBRG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.